Incorporation of a Toll-like receptor 2/6 agonist potentiates mRNA vaccines against cancer and infectious diseases

mRNA vaccines have emerged rapidly in recent years as a prophylactic and therapeutic agent against various diseases including cancer and infectious diseases. Improvements of mRNA vaccines have been underway, among which boosting of efficacy is of great importance. Pam2Cys, a simple synthetic metabol...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yangzhuo, Yang, Jingyun, He, Cai, Zhao, Tingmei, Lu, Ran, Liu, Jian, Mo, Xianming, Wen, Fuqiang, Shi, Huashan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350459/
https://www.ncbi.nlm.nih.gov/pubmed/37455272
http://dx.doi.org/10.1038/s41392-023-01479-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350459/
https://www.ncbi.nlm.nih.gov/pubmed/37455272
http://dx.doi.org/10.1038/s41392-023-01479-4

Ejemplares similares